Objective: To evaluate cluster of differentiation (CD)127 expression in T cells of patients with HIV-1 and the relationship of CD127 expression with disease progression.
There is growing recognition among health-care professionals that human immunodeficiency virus 1 (HIV-1) infection leads to activation of the immune system, [1] [2] [3] [4] [5] [6] and that cluster of differentiation (CD)4 þ T-cell depletion is linked directly to immune-system activation (hereinafter, immune activation). [3] [4] [5] [6] [7] The increased immune activation not only results in T-cell depletion but also leads to the regenerative exhaustion of the lymphoid system. 8 Highly active antiretroviral therapy (HAART) can lead to an increase in the number of CD4 þ , especially naïve T cells that correlate with an increase in thymus volume and neolymphopoiesis. 9 However, how different subsets of CD4 þ T cells in HIV-1 infected patients are changed and transferred during HAART is still unclear. Accordingly, the reciprocal expression of CD45RO and CD45RA isoforms mainly are used to identify human memory and naïve T cells. 10 Many studies [10] [11] [12] have demonstrated that CD45RO þ T cells are more easily infected compared with CD45RA þ T cells in HIV-1 infected patients. Helbert et al 12 found that purified CD45RO þ T cells sustained higher levels of HIV-1 replication than CD45RA
þ T cells because CD45RA þ T cells required special antigen-presenting cells such as dendritic cells for forceful co-stimulation. Nevertheless, the molecular and cellular mechanisms that illustrate the contribution of memory and naïve T cells to HIV-1 infection have not been demonstrated in the literature.
Abbreviations:
HIV-1, human immunodeficiency virus 1; CD, cluster of differentiation; HAART, highly active antiretroviral therapy; IL-7R, interleukin-7 receptor; EDTA, ethylenediaminetetraacetic acid; APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; ANOVA, analysis of variance Certain studies [13] [14] [15] report that the expression of CD127, known as the interleukin-7 receptor (IL-7R) a chain, on the surface of T cells is involved in the regulatory mechanism of IL-7-induced promotion to maturation of thymocytes and the survival and function of T cells, maintaining homeostatic expansion in T-cell subpopulations, and immune response after viral infection. Recent research findings 15 indicate that lack of CD127 on the T-cell surface resulted in a negative effect on the production of T cells. CD127 is regarded as a key factor in the dynamic regulation of the whole T-cell compartment, especially in maintenance of entire naïve and memory T cells. 14 Thus, many studies have focused on the expression of CD127 for its special effects on lymphocyte differentiation and cellular immunity, particularly the regulation of memory T cells. 16 However, evaluation of
þ T cells and the relationship of that expression with disease progression of patients infected with HIV-1 who have undergone HAART have not yielded conclusive results.
In this study, we investigated the effects of CD127 expression on different subsets of CD4 þ T and CD8 þ T cells in the peripheral blood of patients infected with HIV-1 who have undergone more than 5 years of HAART. We found that CD127 expression was higher in naïve and memory CD4 þ T cells of patients with strong recovery and was correlated with recovery of CD4 þ T-cell counts and naïve subsets. 
Materials and Methods

Participants
Determination of Plasma HIV-RNA
A total of 2 mL of peripheral blood was taken from every subject and drawn into tubes containing ethylenediaminetetra acetic acid (EDTA). We used an HIV-1 Monitor 1.5 commercial kit (F. Hoffman-La Roche Ltd) and COBAS Amplisemsor-PCR (Roche Molecular Diagnostics) for quantitative analysis of the HIV-1-RNA of the plasma specimens. We conducted all steps of our experiments in strict accordance with the instructions provided by the manufacturers.
Analysis via Flow Cytometry
We analyzed the expression of various phenotypic markers on the blood specimens via 4-color flow cytometry using the FACScan instrument (Becton Dickinson and Company) and a commercial flow-cytometry assay. Cell staining was performed according to the protocol described by the manufacturer. The absolute cell counts for CD3 þ CD4 þ and CD3 þ CD8 þ T lymphocytes were determined using allophycocyanin C (APC) and anti-CD4-fluorescein isothiocyanate (FITC) or anti-CD8-FITC. We analyzed naïve and memory subsets and CD127 expression of CD4 þ and CD8 þ T lymphocytes using anti-CD127-phycoerythrin (PE), anti-CD45RA-PE-Cy7, or anti-CD45RO-PE-Cy7. The counts and percentages of CD3
were assessed. The gating strategy is shown in Figure 1A .
Statistical Analysis
Data were expressed as mean (SE) ð x 6sÞ. We performed statistical analyses using SPSS for Windows software, version 20.0 (SPSS Inc). The Student's t-test was used to compare between 2 groups; a 1-way analysis of variance (ANOVA) was used when comparing 3 or more groups. We tested correlation using the Spearman correlation test. All tests were 2-tailed, and P values of less than .05 were considered statistically significant.
Results
Comparison of CD4 1 and CD8
T-Cell Counts Among 4 Groups of Subjects
Of the 139 patients infected with HIV-1, 32 had poor recovery, 39 had general recovery, and 68 had strong recovery. The mean level of plasma HIV-RNA in patients with poor recovery was much higher than that in patients with general and good recovery (P <.05). The mean (SE) HAART durations in the 3 groups of patients with HIV-1 were 7.3 (3.6), 8.4 (4.8), and 7.6 (4.5) years, respectively. The CD4 þ Tcell counts of patients infected with HIV-1 were significantly lower than those levels in the control group (P <.05). With a long-term course of HAART, these patients manifested significant differences in CD4 þ T-cell recovery. The CD4 þ Tcell counts were much lower in patients with poor recovery than in other patients (P <.05). In addition, the CD8 þ T-cell counts in the patients were significantly higher than that in the control group (P <.05) ( Table 1 ). The CD8 þ T-cell counts were inversely proportional to the CD4 þ T-cell counts in
Figure 1
The representative histograms of flow cytometry. SSC indicates side scatter; FSC, front scatter; APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin. A, The gating strategy of flow cytometry for detecting cluster of differentiation (CD)4 þ and CD8 þ T-cell subsets and CD127 expression. B, The representative results of CD45RO þ subsets and CD127 expression for CD4 þ and CD8 þ T cells in 4 groups of subjects. The dots in gates P6 and P7 represent CD4 þ T cell and CD4þCD45RA þ T-cell counts in patients with poor and general recovery were significantly lower than those in the control group (P <.05). Also, the counts of CD8þCD45RO þ T cells and CD8þCD45RA þ T cells in patients with poor and general recovery were significantly higher than those in the control group (P <.05). CD4þCD45RO þ T cell and CD4þCD45RA þ T-cell counts in patients with good recovery were at near-normal levels (P> .05) and were much higher than those in patients with poor recovery (P <.05). CD8þCD45RO þ T-cell and CD8þCD45RA þ T-cell counts in patients with good recovery were also at near-normal levels(P> .05) and were lower than those in patients with poor recovery (P <.05) ( Figure 1B and Figure 2A) . However, the percentages of CD4þCD45RO þ T cells and CD8þCD45RO þ T cells in patients with poor and general recovery were much higher than those in control and good-recovery groups (P <.05), and the percentages of CD4þCD45RA þ T cells and CD8þCD45RA þ T cells in patients with poor and general recovery were lower than those in the control and good-recovery groups (P <.05) ( Figure 1B and Figure 2B ).
Changes in CD127 Expression on CD4 1 T-Cell and CD8
1 T-Cell Subsets After HAART
T-cell counts of CD4
þ T-cell subsets in patients with poor and general recovery were lower than those in the control group (P <.05). Also, the CD127 þ T-cell counts of CD8 þ T-cell subsets in patients with poor and general recovery were higher than those in the control group (P
<.05). With recovery of CD4
þ T cells, CD127 þ T-cell counts of CD4þCD45RO þ T-cell and CD4þCD45RA þ T-cell subsets in patients with good recovery were increased (P <.05) ( Figure 1B and Figure 3A ). Similar to CD127 þ T-cell counts, percentages of CD127 þ T cells in CD4 þ T-cell subsets were lower in patients with poor and general recovery than in the control and good-recovery groups (P <.05) ( Figure 1B and Figure 3B ). As in changes of CD127 þ expression in CD4 þ Tcell subsets, percentages of CD127þCD8 þ T cells also were lower in patients with poor and general recovery (P <.05), which was contrary to the counts of CD8 þ T-cell subsets.
CD127
þ percentages of CD4 þ and CD8 þ T cells in patients with good recovery were at near normal levels (P> .05) ( Figures 1B and Figure 3B ).
Correlation between the Expression of CD127 and Different CD4 1 T-Cell and CD8 CD4þCD45RO þ , and CD4þCD45RA þ T-cell counts, respectively (P <.05). The CD8þCD45ROþCD127 þ T-cell counts had significant positive correlation with CD8þCD45RO þ T cells, and CD8þCD45RAþCD127 þ T-cell counts had significant correlation with CD8þCD45RA þ T cells (P <.05) ( Table 2) . Percentages of CD4þCD45RAþCD127þ and CD8þCD45ROþCD127þ were positively correlated with CD4 þ T-cell counts (P <.05).
1
T-Cell Subsets
Percentages of CD127
þ were positively correlated with percentages of CD45RA þ subsets (P <.05). However, those patients cannot recover from insufficiency of CD4 þ T-cell counts and function. 17 Detailed study of T-cell subsets of patients infected with HIV-1 can provide additional information. In our study, CD4 þ T cells increased in various degrees with more than 5 years of HAART, but this level did not reach the same levels observed in healthy control individuals, despite undetectable HIV-1 RNA in the plasma in some patients. We also discovered that CD8 HIV infection can result not only in changes of CD4 þ and CD8 þ T-cell number but also the disorder of T-cell subtype proportion. 12, 18, 19 deficiency. 25 Substantial disruption of the IL-7/IL-7R pathway has been described as a specific characteristic of HIV infection. [26] [27] [28] HAART can reverse the decrease of CD127 expression, which is related to recovery of T cells. 29, 30 Our study found that CD127 expression (percentage of CD127 þ cells) on naïve and memory T-cell subsets of patients infected with HIV-1 generally had declined, compared with the control group, and could be recovered by effective HAART. The decline of CD127 expression in T cells may be related to high immune activation in patients with HIV-1. Two studies 31, 32 reported inverse correlation between CD127 expression and viral load or immune activation. The IL-7/CD127 system can be destroyed by immune activation in T cells. 16 Our results also dictated that the recovery of CD127 expression on T cells in patients with HIV-1 who had undergone long-term HAART was related to disease progression. Subjects with viral suppression had a higher proportion of CD127 þ T cells, for naïve and memory T-cell subsets. We also found that CD127 expression was positively correlated with CD4 þ T-cell counts.
The positive correlation of CD127 expression and percentage of naïve T cells indicates that high expression of CD127 has an important role in maintaining the naïve T-cell proportion.
In summary, our study results indicate that the transformation from naïve to memory subsets in CD4 þ and CD8 þ T cells in patients infected with HIV-1 can be reversed by HAART. CD127 expression in T cells was related to disease progression of HIV-1 infection and correlated with recovery of CD4 þ T-cell counts and proportion of naïve subsets. LM
